aluates Reports

$ 0.0

Automative

Global Oral Mesalazine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-35D12769

Global Oral Mesalazine Market Research Report 2023

BUY CHAPTERS

Global Oral Mesalazine Market Research Report 2025

Code: QYRE-Auto-35D12769

Report

May 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Shire Plc

Salix Pharmaceuticals

Ferring Global

Teva Pharmaceutical Industries

Morningside Healthcare

Tillotts Pharma

Dr. Falk Pharma UK

Nogra Pharma Limited

Oral Mesalazine Market Size

The global market for Oral Mesalazine was valued at US$ 93.2 million in the year 2024 and is projected to reach a revised size of US$ 120 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Oral Mesalazine Market

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn"s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Mesalazine.

The Oral Mesalazine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Mesalazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Mesalazine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Mesalazine Market Report

Report Metric	Details
Report Name	Oral Mesalazine Market
Accounted market size in year	US$ 93.2 million
Forecasted market size in 2031	US$ 120 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablets Capsules Granule
Segment by Application	Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries, Morningside Healthcare, Dr. Falk Pharma UK, Nogra Pharma Limited, Tillotts Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Mesalazine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Mesalazine Market growing?

Ans: The Oral Mesalazine Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Oral Mesalazine Market size in 2031?

Ans: The Oral Mesalazine Market size in 2031 will be US$ 120 million.

Who are the main players in the Oral Mesalazine Market report?

Ans: The main players in the Oral Mesalazine Market are AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries, Morningside Healthcare, Dr. Falk Pharma UK, Nogra Pharma Limited, Tillotts Pharma

What are the Application segmentation covered in the Oral Mesalazine Market report?

Ans: The Applications covered in the Oral Mesalazine Market report are Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease, Others

What are the Type segmentation covered in the Oral Mesalazine Market report?

Ans: The Types covered in the Oral Mesalazine Market report are Tablets, Capsules, Granule

Recommended Reports

Oral Drugs

Bowel Disease Drugs

Active Ingredients & APIs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Mesalazine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tablets

1.2.3 Capsules

1.2.4 Granule

1.3 Market by Application

1.3.1 Global Oral Mesalazine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Ulcerative Colitis

1.3.3 Crohn's Disease

1.3.4 Inflammatory Bowel Disease

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Mesalazine Market Perspective (2020-2031)

2.2 Global Oral Mesalazine Growth Trends by Region

2.2.1 Global Oral Mesalazine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Mesalazine Historic Market Size by Region (2020-2025)

2.2.3 Oral Mesalazine Forecasted Market Size by Region (2026-2031)

2.3 Oral Mesalazine Market Dynamics

2.3.1 Oral Mesalazine Industry Trends

2.3.2 Oral Mesalazine Market Drivers

2.3.3 Oral Mesalazine Market Challenges

2.3.4 Oral Mesalazine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Mesalazine Players by Revenue

3.1.1 Global Top Oral Mesalazine Players by Revenue (2020-2025)

3.1.2 Global Oral Mesalazine Revenue Market Share by Players (2020-2025)

3.2 Global Oral Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Mesalazine Revenue

3.4 Global Oral Mesalazine Market Concentration Ratio

3.4.1 Global Oral Mesalazine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Mesalazine Revenue in 2024

3.5 Global Key Players of Oral Mesalazine Head office and Area Served

3.6 Global Key Players of Oral Mesalazine, Product and Application

3.7 Global Key Players of Oral Mesalazine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Mesalazine Breakdown Data by Type

4.1 Global Oral Mesalazine Historic Market Size by Type (2020-2025)

4.2 Global Oral Mesalazine Forecasted Market Size by Type (2026-2031)

5 Oral Mesalazine Breakdown Data by Application

5.1 Global Oral Mesalazine Historic Market Size by Application (2020-2025)

5.2 Global Oral Mesalazine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Mesalazine Market Size (2020-2031)

6.2 North America Oral Mesalazine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Mesalazine Market Size by Country (2020-2025)

6.4 North America Oral Mesalazine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Mesalazine Market Size (2020-2031)

7.2 Europe Oral Mesalazine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Mesalazine Market Size by Country (2020-2025)

7.4 Europe Oral Mesalazine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Mesalazine Market Size (2020-2031)

8.2 Asia-Pacific Oral Mesalazine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Mesalazine Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Mesalazine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Mesalazine Market Size (2020-2031)

9.2 Latin America Oral Mesalazine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Mesalazine Market Size by Country (2020-2025)

9.4 Latin America Oral Mesalazine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Mesalazine Market Size (2020-2031)

10.2 Middle East & Africa Oral Mesalazine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Mesalazine Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Mesalazine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Oral Mesalazine Introduction

11.1.4 AbbVie Revenue in Oral Mesalazine Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Shire

11.2.1 Shire Company Details

11.2.2 Shire Business Overview

11.2.3 Shire Oral Mesalazine Introduction

11.2.4 Shire Revenue in Oral Mesalazine Business (2020-2025)

11.2.5 Shire Recent Development

11.3 Salix Pharmaceuticals

11.3.1 Salix Pharmaceuticals Company Details

11.3.2 Salix Pharmaceuticals Business Overview

11.3.3 Salix Pharmaceuticals Oral Mesalazine Introduction

11.3.4 Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2020-2025)

11.3.5 Salix Pharmaceuticals Recent Development

11.4 Ferring Global

11.4.1 Ferring Global Company Details

11.4.2 Ferring Global Business Overview

11.4.3 Ferring Global Oral Mesalazine Introduction

11.4.4 Ferring Global Revenue in Oral Mesalazine Business (2020-2025)

11.4.5 Ferring Global Recent Development

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Details

11.5.2 Teva Pharmaceutical Industries Business Overview

11.5.3 Teva Pharmaceutical Industries Oral Mesalazine Introduction

11.5.4 Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2020-2025)

11.5.5 Teva Pharmaceutical Industries Recent Development

11.6 Morningside Healthcare

11.6.1 Morningside Healthcare Company Details

11.6.2 Morningside Healthcare Business Overview

11.6.3 Morningside Healthcare Oral Mesalazine Introduction

11.6.4 Morningside Healthcare Revenue in Oral Mesalazine Business (2020-2025)

11.6.5 Morningside Healthcare Recent Development

11.7 Dr. Falk Pharma UK

11.7.1 Dr. Falk Pharma UK Company Details

11.7.2 Dr. Falk Pharma UK Business Overview

11.7.3 Dr. Falk Pharma UK Oral Mesalazine Introduction

11.7.4 Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2020-2025)

11.7.5 Dr. Falk Pharma UK Recent Development

11.8 Nogra Pharma Limited

11.8.1 Nogra Pharma Limited Company Details

11.8.2 Nogra Pharma Limited Business Overview

11.8.3 Nogra Pharma Limited Oral Mesalazine Introduction

11.8.4 Nogra Pharma Limited Revenue in Oral Mesalazine Business (2020-2025)

11.8.5 Nogra Pharma Limited Recent Development

11.9 Tillotts Pharma

11.9.1 Tillotts Pharma Company Details

11.9.2 Tillotts Pharma Business Overview

11.9.3 Tillotts Pharma Oral Mesalazine Introduction

11.9.4 Tillotts Pharma Revenue in Oral Mesalazine Business (2020-2025)

11.9.5 Tillotts Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Shire Plc

Salix Pharmaceuticals

Ferring Global

Teva Pharmaceutical Industries

Morningside Healthcare

Tillotts Pharma

Dr. Falk Pharma UK

Nogra Pharma Limited

List of Tables

Table 1. Global Oral Mesalazine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tablets

Table 3. Key Players of Capsules

Table 4. Key Players of Granule

Table 5. Global Oral Mesalazine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oral Mesalazine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Mesalazine Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oral Mesalazine Market Share by Region (2020-2025)

Table 9. Global Oral Mesalazine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oral Mesalazine Market Share by Region (2026-2031)

Table 11. Oral Mesalazine Market Trends

Table 12. Oral Mesalazine Market Drivers

Table 13. Oral Mesalazine Market Challenges

Table 14. Oral Mesalazine Market Restraints

Table 15. Global Oral Mesalazine Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oral Mesalazine Market Share by Players (2020-2025)

Table 17. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2024)

Table 18. Ranking of Global Top Oral Mesalazine Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oral Mesalazine Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oral Mesalazine, Headquarters and Area Served

Table 21. Global Key Players of Oral Mesalazine, Product and Application

Table 22. Global Key Players of Oral Mesalazine, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oral Mesalazine Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oral Mesalazine Revenue Market Share by Type (2020-2025)

Table 26. Global Oral Mesalazine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oral Mesalazine Revenue Market Share by Type (2026-2031)

Table 28. Global Oral Mesalazine Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oral Mesalazine Revenue Market Share by Application (2020-2025)

Table 30. Global Oral Mesalazine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oral Mesalazine Revenue Market Share by Application (2026-2031)

Table 32. North America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oral Mesalazine Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oral Mesalazine Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oral Mesalazine Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oral Mesalazine Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oral Mesalazine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oral Mesalazine Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oral Mesalazine Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oral Mesalazine Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oral Mesalazine Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oral Mesalazine Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oral Mesalazine Market Size by Country (2026-2031) & (US$ Million)

Table 47. AbbVie Company Details

Table 48. AbbVie Business Overview

Table 49. AbbVie Oral Mesalazine Product

Table 50. AbbVie Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 51. AbbVie Recent Development

Table 52. Shire Company Details

Table 53. Shire Business Overview

Table 54. Shire Oral Mesalazine Product

Table 55. Shire Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 56. Shire Recent Development

Table 57. Salix Pharmaceuticals Company Details

Table 58. Salix Pharmaceuticals Business Overview

Table 59. Salix Pharmaceuticals Oral Mesalazine Product

Table 60. Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 61. Salix Pharmaceuticals Recent Development

Table 62. Ferring Global Company Details

Table 63. Ferring Global Business Overview

Table 64. Ferring Global Oral Mesalazine Product

Table 65. Ferring Global Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 66. Ferring Global Recent Development

Table 67. Teva Pharmaceutical Industries Company Details

Table 68. Teva Pharmaceutical Industries Business Overview

Table 69. Teva Pharmaceutical Industries Oral Mesalazine Product

Table 70. Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 71. Teva Pharmaceutical Industries Recent Development

Table 72. Morningside Healthcare Company Details

Table 73. Morningside Healthcare Business Overview

Table 74. Morningside Healthcare Oral Mesalazine Product

Table 75. Morningside Healthcare Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 76. Morningside Healthcare Recent Development

Table 77. Dr. Falk Pharma UK Company Details

Table 78. Dr. Falk Pharma UK Business Overview

Table 79. Dr. Falk Pharma UK Oral Mesalazine Product

Table 80. Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 81. Dr. Falk Pharma UK Recent Development

Table 82. Nogra Pharma Limited Company Details

Table 83. Nogra Pharma Limited Business Overview

Table 84. Nogra Pharma Limited Oral Mesalazine Product

Table 85. Nogra Pharma Limited Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 86. Nogra Pharma Limited Recent Development

Table 87. Tillotts Pharma Company Details

Table 88. Tillotts Pharma Business Overview

Table 89. Tillotts Pharma Oral Mesalazine Product

Table 90. Tillotts Pharma Revenue in Oral Mesalazine Business (2020-2025) & (US$ Million)

Table 91. Tillotts Pharma Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Oral Mesalazine Picture

Figure 2. Global Oral Mesalazine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Mesalazine Market Share by Type: 2024 VS 2031

Figure 4. Tablets Features

Figure 5. Capsules Features

Figure 6. Granule Features

Figure 7. Global Oral Mesalazine Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oral Mesalazine Market Share by Application: 2024 VS 2031

Figure 9. Ulcerative Colitis Case Studies

Figure 10. Crohn's Disease Case Studies

Figure 11. Inflammatory Bowel Disease Case Studies

Figure 12. Others Case Studies

Figure 13. Oral Mesalazine Report Years Considered

Figure 14. Global Oral Mesalazine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oral Mesalazine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral Mesalazine Market Share by Region: 2024 VS 2031

Figure 17. Global Oral Mesalazine Market Share by Players in 2024

Figure 18. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Oral Mesalazine Revenue in 2024

Figure 20. North America Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oral Mesalazine Market Share by Country (2020-2031)

Figure 22. United States Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Mesalazine Market Share by Country (2020-2031)

Figure 26. Germany Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Mesalazine Market Share by Region (2020-2031)

Figure 34. China Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Mesalazine Market Share by Country (2020-2031)

Figure 42. Mexico Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Mesalazine Market Share by Country (2020-2031)

Figure 46. Turkey Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oral Mesalazine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 50. Shire Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 52. Ferring Global Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 54. Morningside Healthcare Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 55. Dr. Falk Pharma UK Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 56. Nogra Pharma Limited Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 57. Tillotts Pharma Revenue Growth Rate in Oral Mesalazine Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mesalazine API Market Research Report 2025

Global Mesalamine Market Research Report 2024

Global Mesalamine API Market Research Report 2024

Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesalazine Suppositories Market Research Report 2024

5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balsalazide Disodium Market Research Report 2025

Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030

Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024

Global Adalimumab Market Insights Forecast to 2030

Global Mesalazine Enteric Coated Tablets Market Research Report 2024

Vesanoid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Budesonide Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

5 Fluorosalicylic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sodium 4 Aminosalicylate Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Oral Mesalazine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-35D12769

Global Oral Mesalazine Market Research Report 2025

FEATURED COMPANIES

Oral Mesalazine Market Size

Oral Mesalazine Market

Scope of Oral Mesalazine Market Report

Chapter Outline

FAQ for this report

How fast is Oral Mesalazine Market growing?

What is the Oral Mesalazine Market size in 2031?

Who are the main players in the Oral Mesalazine Market report?

What are the Application segmentation covered in the Oral Mesalazine Market report?

What are the Type segmentation covered in the Oral Mesalazine Market report?

Recommended Reports

Oral Drugs

Bowel Disease Drugs

Active Ingredients & APIs

FEATURED COMPANIES

RELATED REPORTS